OTCMKTS:NUMIF Numinus Wellness (NUMIF) Stock Price, News & Analysis C$0.03 0.00 (0.00%) (As of 07/3/2024 ET) Add Compare Share Share Today's RangeC$0.03▼C$0.0450-Day RangeC$0.03▼C$0.0652-Week RangeC$0.03▼C$0.20Volume61,880 shsAverage Volume280,445 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Numinus Wellness alerts: Email Address Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution About Numinus Wellness Stock (OTCMKTS:NUMIF)Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.Read More NUMIF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUMIF Stock News HeadlinesJune 24, 2024 | prnewswire.comNuminus Wellness Announces Resignation of DirectorJune 20, 2024 | prnewswire.comNuminus Wellness Announces Strategic Acquisition of MedBright AIJuly 3, 2024 | Behind the Markets (Ad)Major Pharma Deals Propel This Undervalued AI StockYou need to check out this game-changing biotech stock. Their physics-based software can model how molecules behave and identify ideal drug candidates in record time. Big Pharma is taking notice.June 7, 2024 | prnewswire.comNuminus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSDMay 31, 2024 | prnewswire.comNuminus Wellness Announces Voting Results From its Annual General Meeting of ShareholdersMay 30, 2024 | prnewswire.comNuminus Wellness Receives Health Canada Approval for Study into Group Model for MDMA-Assisted TherapyMay 7, 2024 | prnewswire.comNuminus Wellness Focused on Boosting Profitability and Expanding Community SupportApril 18, 2024 | uk.investing.comEarnings call: Numinus Wellness reports Q2 fiscal 2024 resultsJuly 3, 2024 | Behind the Markets (Ad)Major Pharma Deals Propel This Undervalued AI StockYou need to check out this game-changing biotech stock. Their physics-based software can model how molecules behave and identify ideal drug candidates in record time. Big Pharma is taking notice.April 17, 2024 | finanznachrichten.deNuminus Wellness Inc.: Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003April 17, 2024 | finance.yahoo.comCedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003April 15, 2024 | benzinga.comNuminus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry TrendsApril 15, 2024 | marketwatch.comNuminus Wellness Shares Down on Canadian Operations ReorganizationApril 15, 2024 | prnewswire.comNuminus Wellness Provides Corporate UpdateApril 12, 2024 | prnewswire.comNuminus Wellness Inc. Announces Second Quarter Fiscal 2024 ResultsApril 9, 2024 | prnewswire.comNuminus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024April 2, 2024 | msn.comOnconova slips after all-stock merger with TrawsfynyddMarch 28, 2024 | ca.finance.yahoo.comTrump Media Goes Public Via SPAC DealMarch 26, 2024 | finance.yahoo.comPharmAla Biotech Signs Sale Agreement with NuminusMarch 26, 2024 | msn.comPharmAla Biotech signs sale agreement with Numinus WellnessMarch 20, 2024 | prnewswire.comNuminus Wellness Submits Clinical Trial ApplicationMarch 12, 2024 | finanznachrichten.deNuminus Wellness Inc.: Numinus Wellness Provides Corporate UpdateMarch 12, 2024 | prnewswire.comNuminus Wellness Provides Corporate UpdateMarch 1, 2024 | seekingalpha.comNUMIF Numinus Wellness Inc.February 23, 2024 | msn.comNuminus CEO Reflects On Monumental Achievement: FDA's Acceptance Of MDMA Therapy ApplicationFebruary 16, 2024 | theglobeandmail.comThis May be One of the Biggest Catalysts for Psychedelic Stocks in 2024February 16, 2024 | finance.yahoo.comNuminus Wellness Inc. Closes $6 Million Bought Deal Public OfferingSee More Headlines Receive NUMIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Numinus Wellness and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:NUMIF CUSIPN/A CIKN/A Webwww.numinus.com Phone(604) 649-3229FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Payton NyquvestFounder, CEO & ChairmanMr. Michael Tan M.B.A.President, COO & DirectorDr. Paul Thielking M.D.Chief Science & Medical OfficerDr. Reid J. Robison M.D. (Age 47)MBA, Chief Clinical Officer Comp: $396.2kMs. Melony Valleau CPA (Age 55)Interim Chief Financial Officer Jamie KokoskaVice President of Investor RelationsMs. Paula Amy Hewitt (Age 51)Senior VP, General Counsel & Chief Privacy Officer Mr. Ian NobleChief Communications OfficerMs. Danielle HinanVice President MarketingMs. Lea BottoniVice President of People & CultureMore ExecutivesKey CompetitorsAmerican Oncology NetworkNASDAQ:AONCWAmerican Oncology NetworkNASDAQ:AONCBangkok Dusit Medical Services PublicOTCMKTS:BDULFBumrungrad Hospital PublicOTCMKTS:BUHPFCareRxOTCMKTS:CHHHFView All Competitors NUMIF Stock Analysis - Frequently Asked Questions How have NUMIF shares performed in 2024? Numinus Wellness' stock was trading at C$0.08 at the beginning of 2024. Since then, NUMIF shares have decreased by 60.4% and is now trading at C$0.03. View the best growth stocks for 2024 here. Are investors shorting Numinus Wellness? Numinus Wellness saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 852,100 shares, a decrease of 23.7% from the May 31st total of 1,116,400 shares. Based on an average trading volume of 1,261,300 shares, the short-interest ratio is currently 0.7 days. View Numinus Wellness' Short Interest. How do I buy shares of Numinus Wellness? Shares of NUMIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NUMIF) was last updated on 7/3/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredRe: We’re giving you all this for less than a pair of socksThe Only Trading Tool You'll Need This Year Forget juggling multiple subscriptions and confusing indicator...StockEarnings | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | Sponsored270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThe End of Privacy for Americans… Get Out of Cash Now!Unlock the Secret to Outsmarting Inflation with "The Trump Loophole" That investment? Gold.Golden Crest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Numinus Wellness Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Numinus Wellness With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.